Regulation of MAP kinases by docking domains

In order to adapt to their environment, cells inte-grate extracellular signals through activation of numer-ous signal transduction pathways that regulate theirmorphology, proliferation, differentiation and survival.The MAP kinases play a central role in these differentprocesses in mammals as well as in other eucaryotes.Extra cellular stimuli initiate cascades of events, which,ultimately, result in the activation of one or moresubset of MAP kinases families (Widmann et al., 1999).To date, five distinct groups of MAP kinases havebeen characterized. The ERK 1/2 (extra-cellular signal-related kinases); JNK 1/2/3 (c-jun amino-terminal ki-nases); p38α, 2, γ, δ; ERK3/4 and ERK5 (Cobb, 1999;Davis, 2000; Nebreda and Porras, 2000; Widmann et al.,1999). The most studied MAPK are the ERK1/2, JNKand p38 MAP kinases. It is generally accepted that, invitro, the ERKs are preferentially activated in responseto growth factors and phorbol esters and associatedwith proliferation and differentiation, while the JNKand p38 MAP kinases are more responsive to a diverseset of stress stimuli ranging from osmotic shock tocytokine stimulation (Pearson et al., 2001).Although one landmark of the MAP kinases is thecomplexity of the signaling cascades that lead to theiractivation, the organisation of these cascades is simpleand conserved between the different families (Wid-mann et al., 1999). Each family of MAP kinases iscomposed of a module of three kinases: a MAP kinasekinase kinase (MAPKKK), which phosphorylates andactivates a MAP kinase kinase (MAPKK), which inturn phosphorylates and activates a MAP kinase(MAPK). MAPKKK, which are serine/threonine ki-nases, are activated after phosphorylation (by ste20-like kinases) or by their interaction with a small GTP-binding protein of the Ras or the Rho family inresponse to extra cellular stimuli (Dan et al., 2001;Kolch, 2000). Activated MAPKs are present in thenucleus where they phosphorylate transcription factors(Brunet et al., 1999; Chen et al., 1992; Gonzalez et al.,1993; Lenormand et al., 1993). The proposed regulatorymechanisms of subcellular localisation upon activationvary depending on the MAPK (Adachi et al., 1999;Adachi et al., 2000; Ben-Levy et al., 1998; Cobb andGoldsmith, 2000; Engel et al., 1998; Tolwinski et al.,1999). In any case, once activated, MAPK phosphory-late a wide range of substrates in various cellularcompartments. To date 14 MAPKKK, 7 MAPKK and 12MAPK have been identified in mammalian cells. Overthe past few years, genetic and pharmacological ap-proaches have been essential to gain information onthe physiological roles of the different MAP kinases(Chang and Karin, 2001; Cohen, 1999). Specific inhibi-tors of enzymes from the MAPK families have beenwidely used in cell culture and in animals (Awad et al.,2000; Barone et al., 2001; Cohen, 1997). Some of the

[1]  T. Toda,et al.  The MAPK kinase Pek1 acts as a phosphorylation-dependent molecular switch , 1999, Nature.

[2]  H. Enslen,et al.  Growth Regulation via p38 Mitogen-activated Protein Kinase in Developing Liver* , 2000, The Journal of Biological Chemistry.

[3]  A. Brunet,et al.  Identification of MAP Kinase Domains by Redirecting Stress Signals into Growth Factor Responses , 1996, Science.

[4]  Shuang Huang,et al.  Induction of Apoptosis by SB202190 through Inhibition of p38β Mitogen-activated Protein Kinase* , 1998, Journal of Biological Chemistry.

[5]  S. Keyse Protein phosphatases and the regulation of MAP kinase activity. , 1998, Seminars in cell & developmental biology.

[6]  M. Mock,et al.  Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. , 2000, The Biochemical journal.

[7]  A. Porras,et al.  p38 MAP kinases: beyond the stress response. , 2000, Trends in biochemical sciences.

[8]  R. Seger,et al.  Altered Regulation of ERK1b by MEK1 and PTP-SL and Modified Elk1 Phosphorylation by ERK1b Are Caused by Abrogation of the Regulatory C-terminal Sequence of ERKs* , 2001, The Journal of Biological Chemistry.

[9]  H. Rubinfeld,et al.  Identification of a Cytoplasmic-Retention Sequence in ERK2* , 1999, The Journal of Biological Chemistry.

[10]  M. Wilkinson,et al.  Pyp1 and Pyp2 PTPases dephosphorylate an osmosensing MAP kinase controlling cell size at division in fission yeast. , 1995, Genes & development.

[11]  R. Davis,et al.  Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.

[12]  C. Widmann,et al.  Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. , 1999, Physiological reviews.

[13]  A. Brunet,et al.  Substrate Recognition Domains within Extracellular Signal-regulated Kinase Mediate Binding and Catalytic Activation of Mitogen-activated Protein Kinase Phosphatase-3* , 2000, The Journal of Biological Chemistry.

[14]  E. Nishida,et al.  Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase , 1997, The EMBO journal.

[15]  M. Gaestel,et al.  Leptomycin B‐sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation , 1998, The EMBO journal.

[16]  C. Tournier,et al.  The MKK7 Gene Encodes a Group of c-Jun NH2-Terminal Kinase Kinases , 1999, Molecular and Cellular Biology.

[17]  C. Marshall,et al.  The sevenmaker gain‐of‐function mutation in p42 MAP kinase leads to enhanced signalling and reduced sensitivity to dual specificity phosphatase action , 1994, FEBS letters.

[18]  Jiahuai Han,et al.  Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms , 1995, Science.

[19]  Roger J. Davis,et al.  The JIP Group of Mitogen-Activated Protein Kinase Scaffold Proteins , 1999, Molecular and Cellular Biology.

[20]  Mutsuhiro Takekawa,et al.  Protein phosphatase 2Cα inhibits the human stress‐responsive p38 and JNK MAPK pathways , 1998, The EMBO journal.

[21]  R. Flavell,et al.  Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Nishida,et al.  Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions , 2001, The EMBO journal.

[23]  J. Wilsbacher,et al.  The N-terminal ERK-binding Site of MEK1 Is Required for Efficient Feedback Phosphorylation by ERK2 in Vitro and ERK Activation in Vivo * , 1999, The Journal of Biological Chemistry.

[24]  K. Irie,et al.  Purification and Identification of a Major Activator for p38 from Osmotically Shocked Cells , 1996, The Journal of Biological Chemistry.

[25]  P. Cohen,et al.  Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines , 1995, Current Biology.

[26]  W. Kolch Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. , 2000, The Biochemical journal.

[27]  K D Paull,et al.  Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. , 1998, Science.

[28]  Philip R. Cohen,et al.  The development and therapeutic potential of protein kinase inhibitors. , 1999, Current opinion in chemical biology.

[29]  H. Enslen,et al.  T Cells + but Not CD 4 + Apoptosis of CD 8 Kinase In Vivo Selectively Induces Activation of p 38 Mitogen-Activated Protein , 1999 .

[30]  Jonathan A. Cooper,et al.  Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells. , 1992, The Journal of biological chemistry.

[31]  Philip R. Cohen,et al.  Activation of the novel stress‐activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases , 1997, The EMBO journal.

[32]  H. Schaeffer,et al.  Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers , 1999, Molecular and Cellular Biology.

[33]  Cesare Montecucco,et al.  Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ‐induced release of NO and TNFα , 1999 .

[34]  E. Nishida,et al.  A conserved docking motif in MAP kinases common to substrates, activators and regulators , 2000, Nature Cell Biology.

[35]  L. Bardwell,et al.  A conserved motif at the amino termini of MEKs might mediate high-affinity interaction with the cognate MAPKs. , 1996, Trends in biochemical sciences.

[36]  Roger J. Davis,et al.  Selective Activation of p38 Mitogen-activated Protein (MAP) Kinase Isoforms by the MAP Kinase Kinases MKK3 and MKK6* , 1998, The Journal of Biological Chemistry.

[37]  H. Schaeffer,et al.  MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. , 1998, Science.

[38]  Jiahuai Han,et al.  Selective Activation of p38a and p38g by Hypoxia ROLE IN REGULATION OF CYCLIN D1 BY HYPOXIA IN PC12 CELLS* , 1999 .

[39]  E. Goldsmith,et al.  Contributions of the Mitogen-activated Protein (MAP) Kinase Backbone and Phosphorylation Loop to MEK Specificity* , 1996, The Journal of Biological Chemistry.

[40]  Robert J. Lefkowitz,et al.  Identification of a Motif in the Carboxyl Terminus of β-Arrestin2 Responsible for Activation of JNK3* , 2001, The Journal of Biological Chemistry.

[41]  M. Su,et al.  Interferon‐γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway , 1998, The EMBO journal.

[42]  E. Reddy,et al.  Signaling by dual specificity kinases , 1998, Oncogene.

[43]  G. Tsujimoto,et al.  Parallel Regulation of Mitogen-activated Protein Kinase Kinase 3 (MKK3) and MKK6 in Gq-signaling Cascade* , 2001, The Journal of Biological Chemistry.

[44]  E. Goldsmith,et al.  A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation , 1998, Current Biology.

[45]  J. Gutkind,et al.  Regulation of gene expression by the small GTPase Rho through the ERK6 (p38γ) MAP kinase pathway , 2001 .

[46]  A. Brunet,et al.  Nuclear translocation of p42/p44 mitogen‐activated protein kinase is required for growth factor‐induced gene expression and cell cycle entry , 1999, The EMBO journal.

[47]  D. Lawrence,et al.  Multiple Regions of MAP Kinase Phosphatase 3 Are Involved in Its Recognition and Activation by ERK2* , 2001, The Journal of Biological Chemistry.

[48]  A. Ullrich,et al.  PTP‐SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal‐regulated kinases ERK1 and ERK2 by association through a kinase interaction motif , 1998, The EMBO journal.

[49]  Jiahuai Han,et al.  BMK1/ERK5 regulates serum‐induced early gene expression through transcription factor MEF2C , 1997, The EMBO journal.

[50]  E. Goldsmith,et al.  Dimerization in MAP-kinase signaling. , 2000, Trends in biochemical sciences.

[51]  Jiahuai Han,et al.  Cardiac Hypertrophy Induced by Mitogen-activated Protein Kinase Kinase 7, a Specific Activator for c-Jun NH2-terminal Kinase in Ventricular Muscle Cells* , 1998, The Journal of Biological Chemistry.

[52]  T. Maeda,et al.  Activation of yeast PBS2 MAPKK by MAPKKKs or by binding of an SH3-containing osmosensor. , 1995, Science.

[53]  M. Assanah,et al.  Biochemical and Biological Functions of the N-Terminal, Noncatalytic Domain of Extracellular Signal-Regulated Kinase 2 , 2001, Molecular and Cellular Biology.

[54]  E. Nishida,et al.  A Novel Regulatory Mechanism in the Mitogen-activated Protein (MAP) Kinase Cascade , 1997, The Journal of Biological Chemistry.

[55]  I. Ota,et al.  Two Protein-tyrosine Phosphatases Inactivate the Osmotic Stress Response Pathway in Yeast by Targeting the Mitogen-activated Protein Kinase, Hog1* , 1997, The Journal of Biological Chemistry.

[56]  P. Cohen,et al.  The search for physiological substrates of MAP and SAP kinases in mammalian cells. , 1997, Trends in cell biology.

[57]  M. Cobb,et al.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.

[58]  R. Flavell,et al.  Activation of the p38 Mitogen-Activated Protein Kinase Pathway Arrests Cell Cycle Progression and Differentiation of Immature Thymocytes in Vivo , 2000, The Journal of experimental medicine.

[59]  N. Ahn,et al.  Nuclear Localization of Mitogen-activated Protein Kinase Kinase 1 (MKK1) Is Promoted by Serum Stimulation and G2-M Progression , 1999, The Journal of Biological Chemistry.

[60]  C. Marshall,et al.  Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2 , 1998, Current Biology.

[61]  M. Karin,et al.  Mammalian MAP kinase signalling cascades , 2001, Nature.

[62]  R. Davis,et al.  MAPKs: new JNK expands the group. , 1994, Trends in biochemical sciences.

[63]  A. Sharrocks,et al.  Docking domains and substrate-specificity determination for MAP kinases. , 2000, Trends in biochemical sciences.

[64]  M Dickens,et al.  Interaction of a Mitogen-Activated Protein Kinase Signaling Module with the Neuronal Protein JIP3 , 2000, Molecular and Cellular Biology.

[65]  M. Muda,et al.  The Mitogen-activated Protein Kinase Phosphatase-3 N-terminal Noncatalytic Region Is Responsible for Tight Substrate Binding and Enzymatic Specificity* , 1998, The Journal of Biological Chemistry.

[66]  E. Nishida,et al.  Nuclear Export of Map Kinase (ERK) Involves a Map Kinase Kinase (Mek-Dependent) Active Transport Mechanism , 2000, The Journal of cell biology.

[67]  M. Gabrielsen,et al.  Distinct Binding Determinants for ERK2/p38α and JNK MAP Kinases Mediate Catalytic Activation and Substrate Selectivity of MAP Kinase Phosphatase-1* 210 , 2001, The Journal of Biological Chemistry.

[68]  T. Hunter,et al.  Signaling—2000 and Beyond , 2000, Cell.

[69]  H. Enslen,et al.  Molecular determinants that mediate selective activation of p38 MAP kinase isoforms , 2000, The EMBO journal.

[70]  R. Davis,et al.  Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. , 1998, Trends in biochemical sciences.

[71]  C. Der,et al.  The Mitogen-activated Protein Kinase Phosphatases PAC1, MKP-1, and MKP-2 Have Unique Substrate Specificities and Reduced Activity in Vivo toward the ERK2 sevenmaker Mutation (*) , 1996, The Journal of Biological Chemistry.

[72]  T. Mustelin,et al.  Negative Regulation of T Cell Antigen Receptor Signal Transduction by Hematopoietic Tyrosine Phosphatase (HePTP)* , 1998, The Journal of Biological Chemistry.

[73]  Jiahuai Han,et al.  Characterization of the Structure and Function of a Novel MAP Kinase Kinase (MKK6) (*) , 1996, The Journal of Biological Chemistry.

[74]  A. Brunet,et al.  Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts , 1993, The Journal of cell biology.

[75]  Jiahuai Han,et al.  Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. , 1999, The Journal of biological chemistry.

[76]  Masahiko Watanabe,et al.  MKP-7, a Novel Mitogen-activated Protein Kinase Phosphatase, Functions as a Shuttle Protein* , 2001, The Journal of Biological Chemistry.

[77]  G. V. Vande Woude,et al.  Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[78]  M. Karin,et al.  JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension. , 1998, Genes & development.

[79]  E. Hafen,et al.  A gain-of-function mutation in Drosophila MAP kinase activates multiple receptor tyrosine kinase signaling pathways , 1994, Cell.

[80]  M. Cobb,et al.  The Mitogen-Activated Protein Kinase p38-2 Is Necessary for the Inhibition of N-Type Calcium Current by Bradykinin , 1998, The Journal of Neuroscience.

[81]  A. Ashworth,et al.  MKP5, a new member of the MAP kinase phosphatase family, which selectively dephosphorylates stress-activated kinases , 1999, Oncogene.

[82]  E. Nishida,et al.  Cytoplasmic Localization of Mitogen-activated Protein Kinase Kinase Directed by Its NH2-terminal, Leucine-rich Short Amino Acid Sequence, Which Acts as a Nuclear Export Signal* , 1996, The Journal of Biological Chemistry.

[83]  M. Gorospe,et al.  Discordance between the Binding Affinity of Mitogen-activated Protein Kinase Subfamily Members for MAP Kinase Phosphatase-2 and Their Ability to Activate the Phosphatase Catalytically* , 2001, The Journal of Biological Chemistry.

[84]  Carmen Blanco-Aparicio,et al.  A Novel Regulatory Mechanism of Map Kinases Activation and Nuclear Translocation Mediated by Pka and the Ptp-Sl Tyrosine Phosphatase , 1999, The Journal of cell biology.

[85]  T. Pawson,et al.  Protein-protein interactions define specificity in signal transduction. , 2000, Genes & development.

[86]  R. Davis,et al.  MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.

[87]  R. Davis,et al.  Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus , 1993, The Journal of cell biology.

[88]  J. Blenis,et al.  Nuclear localization and regulation of erk- and rsk-encoded protein kinases , 1992, Molecular and cellular biology.

[89]  M. Muda,et al.  Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. , 1998, Science.

[90]  Norinobu M. Watanabe,et al.  The Ste20 group kinases as regulators of MAP kinase cascades. , 2001, Trends in cell biology.

[91]  J. Ninomiya-Tsuji,et al.  Regulation of the TAK1 Signaling Pathway by Protein Phosphatase 2C* , 2001, The Journal of Biological Chemistry.

[92]  M. Camps,et al.  Dual specificity phosphatases: a gene family for control of MAP kinase function , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[93]  T. Maeda,et al.  Regulation of the Saccharomyces cerevisiae HOG1 mitogen-activated protein kinase by the PTP2 and PTP3 protein tyrosine phosphatases , 1997, Molecular and cellular biology.

[94]  R. Lefkowitz,et al.  Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. , 2000, Science.

[95]  E. Nishida,et al.  Two co‐existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimer , 1999, The EMBO journal.

[96]  S. Kassis,et al.  SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. , 2001, The Journal of pharmacology and experimental therapeutics.

[97]  Jiahuai Han,et al.  Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. , 2000, Genes & development.

[98]  J Ross,et al.  Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family* , 1998, The Journal of Biological Chemistry.

[99]  M. Cobb,et al.  Hydrophobic as Well as Charged Residues in Both MEK1 and ERK2 Are Important for Their Proper Docking* , 2001, The Journal of Biological Chemistry.

[100]  Robert J. Lefkowitz,et al.  Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[101]  E. Nishida,et al.  A Novel MAPK Phosphatase MKP-7 Acts Preferentially on JNK/SAPK and p38α and β MAPKs* , 2001, The Journal of Biological Chemistry.

[102]  E. Goldsmith,et al.  Phosphorylation of MAP Kinases by MAP/ERK Involves Multiple Regions of MAP Kinases* , 1999, The Journal of Biological Chemistry.

[103]  Y. Yanagawa,et al.  Selective suppression of stress‐activated protein kinase pathway by protein phosphatase 2C in mammalian cells , 1998, FEBS letters.

[104]  B. Cairns,et al.  Signaling in the yeast pheromone response pathway: specific and high-affinity interaction of the mitogen-activated protein (MAP) kinases Kss1 and Fus3 with the upstream MAP kinase kinase Ste7 , 1996, Molecular and cellular biology.

[105]  J. Yasuda,et al.  A mammalian scaffold complex that selectively mediates MAP kinase activation. , 1998, Science.

[106]  L. Flatauer,et al.  A Conserved Docking Site in MEKs Mediates High-affinity Binding to MAP Kinases and Cooperates with a Scaffold Protein to Enhance Signal Transmission* , 2001, The Journal of Biological Chemistry.

[107]  P. Cohen,et al.  Stress-activated Protein Kinase-2/p38 and a Rapamycin-sensitive Pathway Are Required for C2C12 Myogenesis* , 1999, The Journal of Biological Chemistry.

[108]  Philip R. Cohen,et al.  SKK4, a novel activator of stress‐activated protein kinase‐1 (SAPK1/JNK) , 1997, FEBS letters.

[109]  R. Flavell,et al.  MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. , 2001, Genes & development.